{
    "xml": "<topic id=\"PHP3818\" outputclass=\"drug\" rev=\"1.17\" type=\"drug\" namespace=\"/drugs/tipranavir\" basename=\"tipranavir\" title=\"TIPRANAVIR\">\n<title>TIPRANAVIR</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_1055\" namespace=\"/interactions/list-of-drug-interactions/antivirals/tipranavir\">Tipranavir</xref>\n</p>\n<data name=\"vtmid\">418721002</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_643762552\" title=\"Protease inhibitors (HIV)\">Protease inhibitors (HIV)</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34642\" title=\"PROTEASE INHIBITORS\" namespace=\"/drug-classes/protease-inhibitors\">PROTEASE INHIBITORS</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP56778\" outputclass=\"indicationsAndDose\" rev=\"1.17\" parent=\"/drugs/tipranavir\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">HIV infection resistant to other protease inhibitors, in combination with other antiretroviral drugs in patients previously treated with antiretrovirals (with low-dose ritonavir)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth using capsules</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>500&#8239;mg twice daily.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"doseEquivalence\">\n<title>Dose equivalence and conversion</title>\n<p>The bioavailability of tipranavir oral solution is higher than that of the capsules; the oral solution is not interchangeable with the capsules on a milligram-for-milligram basis.</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP56847\" outputclass=\"cautions\" rev=\"1.17\" parent=\"/drugs/tipranavir\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Patients at risk of increased bleeding from trauma, surgery or other pathological conditions</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP56769\" outputclass=\"interactions\" rev=\"1.7\" parent=\"/drugs/tipranavir\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (tipranavir).</p>\n<p>Caution with concomitant use of drugs that increase risk of bleeding.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP56707\" outputclass=\"sideEffects\" rev=\"1.16\" parent=\"/drugs/tipranavir\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"rare\">\n<p outputclass=\"title\">Rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Dehydration</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Anorexia</ph>; <ph outputclass=\"sideEffect\">dyspnoea</ph>; <ph outputclass=\"sideEffect\">influenza-like symptoms</ph>; <ph outputclass=\"sideEffect\">peripheral neuropathy</ph>; <ph outputclass=\"sideEffect\">photosensitivity</ph>; <ph outputclass=\"sideEffect\">renal impairment</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsAdvice\">\n<title>Side-effects, further information</title>\n<sectiondiv>\n<p outputclass=\"title\">Hepatotoxicity</p>\n<p>Potentially life-threatening hepatotoxicity reported. Discontinue if signs or symptoms of hepatitis develop or if liver-function abnormality develops (consult product literature).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP56758\" outputclass=\"pregnancy\" parent=\"/drugs/tipranavir\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises use only if potential benefit outweighs risk&#8212;toxicity in <i>animal </i>studies.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP56792\" outputclass=\"hepaticImpairment\" parent=\"/drugs/tipranavir\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises caution in mild impairment; avoid in moderate or severe impairment&#8212;no information available.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP56648\" outputclass=\"monitoringRequirements\" parent=\"/drugs/tipranavir\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"patientMonitoringProgrammes\">\n<sectiondiv>\n<p>Monitor liver function before treatment then every 2 weeks for 1 month, then every 3 months.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP58633\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.8\" parent=\"/drugs/tipranavir\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p>Flavours of oral liquid formulations may include toffee and mint.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP56746\" outputclass=\"patientAndCarerAdvice\" rev=\"1.9\" parent=\"/drugs/tipranavir\">\n<title>Patient and carer advice</title>\n<body>\n<section outputclass=\"generalPatientAdvice\">\n<sectiondiv>\n<p>Patients or carers should be told to observe the oral solution for crystallisation; the bottle should be replaced if more than a thin layer of crystals form (doses should continue to be taken at the normal time until the bottle is replaced).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP3818-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/tipranavir\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76939\" title=\"Capsule\" namespace=\"/drugs/tipranavir/capsule\">Capsule</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76944\" title=\"Oral solution\" namespace=\"/drugs/tipranavir/oral-solution\">Oral solution</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78275\" namespace=\"/treatment-summaries/hiv-infection\" title=\"HIV infection\" count=\"2\" rel=\"backlink\">HIV infection</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_1055\" namespace=\"/interactions/list-of-drug-interactions/antivirals/tipranavir\" title=\"Tipranavir\" count=\"1\" rel=\"link\">Tipranavir</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34642\" namespace=\"/drug-classes/protease-inhibitors\" title=\"PROTEASE INHIBITORS\" count=\"1\" rel=\"link\">PROTEASE INHIBITORS</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76939\" namespace=\"/drugs/tipranavir/capsule\" title=\"Capsule\" count=\"1\" rel=\"link\">Capsule</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76944\" namespace=\"/drugs/tipranavir/oral-solution\" title=\"Oral solution\" count=\"1\" rel=\"link\">Oral solution</xref>\n</links>\n</topic>",
    "id": "PHP3818",
    "outputclass": "drug",
    "rev": "1.17",
    "type": "drug",
    "namespace": "/drugs/tipranavir",
    "basename": "tipranavir",
    "title": "TIPRANAVIR",
    "interactants": [
        {
            "id": "bnf_int_1055",
            "label": "Tipranavir"
        }
    ],
    "vtmid": "418721002",
    "drugClassification": [
        "Protease inhibitors (HIV)"
    ],
    "inheritsFromClass": [
        "PROTEASE INHIBITORS"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "HIV infection resistant to other protease inhibitors, in combination with other antiretroviral drugs in patients previously treated with antiretrovirals (with low-dose ritonavir)",
                        "html": "HIV infection resistant to other protease inhibitors, in combination with other antiretroviral drugs in patients previously treated with antiretrovirals (with low-dose ritonavir)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth using capsules"
                    ],
                    "textContent": "By mouth using capsules",
                    "html": "By mouth using capsules"
                },
                "adult": [
                    {
                        "textContent": "500 mg twice daily.",
                        "html": "<p>500&#8239;mg twice daily.</p>"
                    }
                ]
            }
        ],
        "doseEquivalence": [
            {
                "type": "doseEquivalence",
                "title": "Dose equivalence and conversion",
                "textContent": "The bioavailability of tipranavir oral solution is higher than that of the capsules; the oral solution is not interchangeable with the capsules on a milligram-for-milligram basis.",
                "html": "<p>The bioavailability of tipranavir oral solution is higher than that of the capsules; the oral solution is not interchangeable with the capsules on a milligram-for-milligram basis.</p>"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Patients at risk of increased bleeding from trauma, surgery or other pathological conditions",
                "html": "Patients at risk of increased bleeding from trauma, surgery or other pathological conditions"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (tipranavir).\n\nCaution with concomitant use of drugs that increase risk of bleeding.",
                "html": "<p>Appendix 1 (tipranavir).</p><p>Caution with concomitant use of drugs that increase risk of bleeding.</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "rare": [
                    {
                        "type": "rare",
                        "textContent": "Dehydration",
                        "html": "Dehydration",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Anorexia",
                        "html": "Anorexia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "dyspnoea",
                        "html": "dyspnoea",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "influenza-like symptoms",
                        "html": "influenza-like symptoms",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "peripheral neuropathy",
                        "html": "peripheral neuropathy",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "photosensitivity",
                        "html": "photosensitivity",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "renal impairment",
                        "html": "renal impairment",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        },
        "advice": [
            {
                "type": "advice",
                "title": "Hepatotoxicity",
                "textContent": "Potentially life-threatening hepatotoxicity reported. Discontinue if signs or symptoms of hepatitis develop or if liver-function abnormality develops (consult product literature).",
                "html": "<p>Potentially life-threatening hepatotoxicity reported. Discontinue if signs or symptoms of hepatitis develop or if liver-function abnormality develops (consult product literature).</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises use only if potential benefit outweighs risk&#8212;toxicity in animal studies.",
                "html": "<p>Manufacturer advises use only if potential benefit outweighs risk&#8212;toxicity in <i>animal </i>studies.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises caution in mild impairment; avoid in moderate or severe impairment&#8212;no information available.",
                "html": "<p>Manufacturer advises caution in mild impairment; avoid in moderate or severe impairment&#8212;no information available.</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "patientMonitoringProgrammes": [
            {
                "type": "patientMonitoringProgrammes",
                "textContent": "Monitor liver function before treatment then every 2 weeks for 1 month, then every 3 months.",
                "html": "<p>Monitor liver function before treatment then every 2 weeks for 1 month, then every 3 months.</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "textContent": "Flavours of oral liquid formulations may include toffee and mint.",
                "html": "<p>Flavours of oral liquid formulations may include toffee and mint.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "generalPatientAdvice": [
            {
                "type": "generalPatientAdvice",
                "textContent": "Patients or carers should be told to observe the oral solution for crystallisation; the bottle should be replaced if more than a thin layer of crystals form (doses should continue to be taken at the normal time until the bottle is replaced).",
                "html": "<p>Patients or carers should be told to observe the oral solution for crystallisation; the bottle should be replaced if more than a thin layer of crystals form (doses should continue to be taken at the normal time until the bottle is replaced).</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP76939",
                "label": "Capsule",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76944",
                "label": "Oral solution",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78275",
                "label": "HIV infection",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_1055",
                "label": "Tipranavir",
                "type": "interaction"
            }
        ],
        "drugClass": [
            {
                "id": "PHP34642",
                "label": "PROTEASE INHIBITORS",
                "type": "drugClass"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP76939",
                "label": "Capsule",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76944",
                "label": "Oral solution",
                "type": "medicinalForm"
            }
        ]
    }
}